Genetic effects on treatment response of umeclidinium/vilanterol in chronic obstructive pulmonary disease. [electronic resource]
Producer: 20171214Description: 123-6 p. digitalISSN:- 1532-3064
- Administration, Inhalation
- Adrenergic beta-2 Receptor Agonists -- therapeutic use
- Aged
- Benzyl Alcohols -- administration & dosage
- Bronchodilator Agents -- therapeutic use
- Chlorobenzenes -- administration & dosage
- Clinical Trials as Topic
- Drug Combinations
- Female
- Forced Expiratory Volume -- drug effects
- Genome-Wide Association Study
- HLA Antigens -- genetics
- Humans
- Male
- Middle Aged
- Muscarinic Antagonists -- therapeutic use
- Pharmacogenetics
- Polymorphism, Single Nucleotide -- genetics
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Quinuclidines -- administration & dosage
- Treatment Outcome
- Vital Capacity -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.